| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |